May 10th 2024
From Big Pharma to biotech—and a globe-spanning journey along the way—Yvonne Greenstreet, this year’s Healthcare Businesswomen’s Association Woman of the Year, is right where she wants to be: leading efforts to advance “bold ideas” in RNAi therapeutics into life-changing gains for patients.
Keeping Cost-Competitive: Milan Kalawadia, Dr. Reddy’s
August 2nd 2021Milan Kalawadia, Senior Vice President, Head of US Commercial Operations at Dr. Reddy‘s, talks about his 15+ years with the India-headquartered company, maintaining a leading position in the generics industry, and the challenges of doing business during the pandemic.
Broadening the Scope of Small Molecules: Ventus Therapeutics
July 13th 2021Marcelo Bigal, M.D, Ph.D, President and CEO of Ventus Therapeutics, talks about how technological innovation in the field of small molecule drug development has created new opportunities for pursuing undruggable targets, building on the well-established strengths of small molecule medicines.
What Does the Future of Work Look Like for America’s Biopharma Sales Force?
June 29th 2021Harvard Business School Professor Joseph B. Fuller talks about the future prospects for pharma sales forces as they face more restrictions on accessing their target physicians and looming concerns of automation.
Protecting Nerve Cells in the Fight Against Alzheimer’s Disease: Dr. Maria Maccecchini
May 14th 2021Annovis Bio's Maria L. Maccecchini, Ph.D., talks about why she, as a scientist and biotech company entrepreneur, became focused on protecting nerve cells in the brain and in the body, as a way to treat neurodegenerative disease.
Commercializing Complex Medicines in Europe: David Johnson, ADVANZ PHARMA
May 12th 2021David Johnson, Global Director Commercial Excellence at ADVANZ PHARMA, talks about the importance of ensuring the continued supply of complex medicines to European hospitals, to enhance access to critical medicines, helping to broaden patient choice and optimize health outcomes.